Riskpilot← Back to searchSign inGet full accessPHARMAVAX HOLDING AS
ASActiveOrg 829046172Jernbaneveien 4, 1400 SkiManufacture of pharmaceutical preparations · NACE 2120Est. 20220 employees
Revenue 2024
NOK 0
EBITDA margin
—
Equity ratio
99.9%
Financial strength
Net profit 2024
NOK 24K
0 employees
| Revenue | NOK 0 | — |
| EBITDA | NOK -26K | — |
| Net profit | NOK 24K | — |
| Total assets | NOK 5,1M | +21176% |
| Equity | NOK 5M | +21149% |
| Employees | 0 | — |
Legal name
PHARMAVAX HOLDING AS
Org number
829046172
Legal form
Aksjeselskap
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
7. april 2022
Share capital
NOK 40 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Forvalte sine eierinteresser, foreta finansielle og industrielle investeringer og tilby administrative tjenester, samt all annen virksomhet som henger naturlig sammen med dette.
Address
Jernbaneveien 4, 1400 Ski
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 |
| EBITDA | −6 | 0 | −26 |
| Depreciation & amort. | −0 | −0 | −0 |
| EBIT | −6 | 0 | −26 |
| Net financials | −1 | 0 | 57 |
| Profit before tax | −6 | 0 | 30 |
| Tax | −0 | −0 | 7 |
| Net profit | −6 | 0 | 24 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 24 | 24 | 5 052 |
| Equity | 24 | 24 | 5 045 |
| Long-term debt | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 7 |
| Total debt | 0 | 0 | 7 |
EBITDA margin
-2646500.0%
This company
15.8%
Market median
-16750100% vs market
20222024
Equity ratio
99.9%
This company
38.2%
Market median
+162% vs market
20222024
Return on equity
0.5%
This company
18.4%
Market median
-97% vs market
20222024
Net profit margin
2351400.0%
This company
8.1%
Market median
+29029530% vs market
20222024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20222024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20222024
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2022 | |
| Board of Directors | 2025 | |
| Board of Directors | 2024 | |
| Board of Directors | 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 33.33% | 33.33% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Wider Holding As
PHARMAVAX HOLDING AS Board members of PHARMAVAX HOLDING AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Geir Ivar Westen | Chairman | 0 companies |
| Karl Iver Hanvold | Board of Directors | 0 companies |
| Morten Gunnar Paulsbo | Board of Directors | 0 companies |
| Magnus Gunnar Paulsbo | Board of Directors | 0 companies |